What Innovative Cell Technologies does

Innovative Cell Technologies, Inc. (ICT) is a privately held San Diego-based manufacturer of enzyme-based cell detachment solutions used in life sciences research and cell therapy manufacturing. The company is the sole worldwide producer of Accutase, a proteolytic and collagenolytic enzyme mixture positioned as a gentle alternative to trypsin for adherent cell culture, and Accumax, a 3x higher-concentration variant for tissue dissociation, spheroid dissolution, and flow cytometry. The product line is completed by AccutaseLZ, a lyophilized format for international shipping, and AccutaseGMP, a cGMP-manufactured version with 20nm virus filtration and a Drug Master File, intended as an ancillary reagent in cell therapy and regenerative medicine manufacturing.

The underlying technology is a non-mammalian, non-bacterial enzyme blend that replaces the multi-step trypsin workflow (wash, neutralize, inactivate) with a single detachment step, with particular traction in stem cell, iPSC, neural, and cardiac workflows. Manufacturing is fully in-house at the company's 6790 Top Gun St facility, which includes ISO 7 and ISO 8 suites, controlled cold storage, and an 18 mega Ohm water system, with all sterile fill and finish performed on site under an ISO 13485:2016 quality system. The company sells directly to US customers via phone, fax, and email and through a global distributor network that includes EMD Millipore, BD Biosciences, Sigma-Aldrich, Fisher Scientific, Corning, Thermo Fisher, STEMCELL Technologies, and regional specialists in Japan, France, Denmark, Canada, Germany, Taiwan, and Malaysia.

Commercial activity is a low-profile, transactionally-priced reagent business: unit prices range from $34 (100ml Accutase) to $530 (500ml AccutaseGMP), with free samples offered to first-time customers. The company practices a stealth go-to-market model, relying on product quality, scientific publications (over 200 papers citing the products), and patent citations (131 granted patents) rather than direct marketing. End customers span academic and government research institutions, biotechs, and biopharma cell therapy developers, with a notable academic testimonial from UCSD's Hebrok Lab citing use in human embryonic and induced pluripotent stem cell culture. Founded around 2001 by Jeff Officer, the company was acquired in the mid-2000s by C. Kevin and Margie Becker, who have since served as co-owners with C. Kevin Becker as President.

Name

Innovative Cell Technologies

Legal name

Innovative Cell Technologies, Inc.

Website

https://accutase.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

1–10 employees

Short description

Innovative Cell Technologies is the sole worldwide manufacturer of Accutase and Accumax, enzyme-based cell detachment solutions sold to academic researchers, biotechs, and cell therapy manufacturers through direct US sales and a global distributor network.

Ownership category

akta.pro rank

Product category

Cell Culture Reagents

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP) (HLAGAGAG)

akta.pro secondary industries

Cell Therapy Enabling Technologies (gene editing, cell engineering, delivery methods) (HLAAABAL), GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification) (HLAGAGAL)

Keywords

• Cell detachment solutions
• Cell culture reagents
• Enzyme-based reagents
• GMP-grade reagents
• Stem cell research products

Headquarters

HQ city

San Diego

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Research-grade Cell Detachment Solutions: One-time purchase of cell culture reagents including Accutase, Accumax, and AccutaseLZ sold directly and through distributors globally. Revenue is transactional with repeat purchases from research laboratories and biopharma companies.
2. GMP-grade AccutaseGMP: Higher-margin GMP-grade cell detachment solution sold directly for use in cell therapy manufacturing and advanced research applications, accompanied by comprehensive documentation package.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Innovative Cell Technologies manufactures and sells enzyme-based cell detachment and dissociation solutions used as gentle replacements for trypsin in cell culture. The product line includes Accutase (standard research grade), Accumax (3X concentration), AccutaseLZ (lyophilized format for international shipping), and AccutaseGMP (cGMP-manufactured for cell therapy and advanced manufacturing use). The company is the sole worldwide manufacturer of Accutase and Accumax.

Product overview

Innovative Cell Technologies manufactures a portfolio of cell detachment solutions, serving as the sole worldwide manufacturer of Accutase and Accumax products. The core offering includes Accutase (standard research grade), Accumax (higher concentration formulation), AccutaseLZ (lyophilized form for international shipping), and AccutaseGMP (GMP-grade for regulated manufacturing use). These enzyme-based reagents serve as gentle replacements for trypsin in cell culture applications, with applications spanning stem cell research, flow cytometry, and general cell passaging. The company operates under ISO 13485:2016 quality management system and brings all manufacturing, including sterile fill and finish, in-house at their San Diego facility.

Differentiator

Problem solved

Functional benefit

Brands

• Accutase: Ready-to-use cell detachment solution, a gentle replacement for trypsin in all adherent cell culture, particularly for sensitive cell types including stem cells.
• Accumax
• AccutaseLZ
• AccutaseGMP

Products and services

• Accutase Ready-to-use cell detachment solution that serves as a gentle replacement for trypsin in all adherent cell culture. Contains proteolytic and collagenolytic enzyme activity formulated at lower concentration than mammalian trypsin, making it less toxic and gentler while remaining effective. Particularly suited for sensitive cell types including embryonic stem cells, induced pluripotent stem cells, neural stem cells, and other stem cells. No washing, neutralization, or inactivation steps are required.
• Accumax Gentle enzyme mixture using the same enzymes as Accutase but formulated at 3X higher concentration without phenol red. Powerful enough to dissociate tissue, dissolve spheroids, eliminate clumps, and extend flow cytometry sorts without harming cells. Used for primary cell dissociation, tissue dissociation, spheroid dissolution, and clump elimination in flow cytometry sample preparation.
• AccutaseLZ Lyophilized (powder) form of Accutase that is stable and convenient, particularly suitable for international customers in difficult shipping situations. Easy to reconstitute and equally effective as the liquid form. Each vial makes 500ml of ready-to-use solution.
• AccutaseGMP GMP-manufactured cell detachment solution formulated with the same ingredients as research-grade Accutase but manufactured under cGMP guidelines. Includes 20nm virus filtration. Intended for research or further manufacturing use as an ancillary reagent. Accompanied by a harmonized documentation package including Drug Master File authorization. Sold solely direct from the company.

Quantifiable outcome

• Over 23,000 Google Scholar listings for Accutase
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

14 partnerships are on record, tiered major, minor and strategic.

• EMD MilliporemajorChannel Partner/ Reseller/ DistributorEMD Millipore distributes Accutase and Accumax products worldwide as part of their life science reagent portfolio.
• BD BiosciencesmajorChannel Partner/ Reseller/ DistributorBD Biosciences distributes Accutase as part of their cell preparation and separation reagents product line.
• Sigma-AldrichmajorChannel Partner/ Reseller/ DistributorSigma-Aldrich distributes Accutase products to researchers worldwide.
• Fisher ScientificmajorChannel Partner/ Reseller/ DistributorFisher Scientific distributes Accutase cell detachment reagent to customers in North America.
• Corning Life SciencesmajorChannel Partner/ Reseller/ DistributorCorning Life Sciences distributes Accutase alongside their cell culture products.
• Thermo Fisher ScientificmajorChannel Partner/ Reseller/ DistributorThermo Fisher distributes Accutase under the StemPro brand name for stem cell research applications.
• eBioscienceminorChannel Partner/ Reseller/ DistributoreBioscience distributes Accutase enzyme cell detachment medium in the United States.
• STEMCELL TechnologiesmajorChannel Partner/ Reseller/ DistributorSTEMCELL distributes Accutase to stem cell research customers globally.
• Pan-BiotechstrategicChannel Partner/ Reseller/ DistributorPan-Biotech is the only company worldwide allowed to bottle Accutase in their own facility under the direct supervision of Innovative Cell Technologies. Represents a unique licensing arrangement in Germany.
• Funakoshi (Japan)minorChannel Partner/ Reseller/ DistributorFunakoshi distributes Accutase and Accumax in Japan.
• Nacalai USAminorChannel Partner/ Reseller/ DistributorNacalai distributes cell culture products including Accutase in the US market.
• Cedar Lane Labs (Canada)minorChannel Partner/ Reseller/ DistributorCedar Lane Labs distributes Accutase products in Canada.
• Interchim (France)minorChannel Partner/ Reseller/ DistributorInterchim distributes Accutase products in France.
• Cytotech (Denmark)minorChannel Partner/ Reseller/ DistributorCytotech distributes Accutase in Denmark.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• STEMCELL Technologies: STEMCELL is both an ICT distribution partner and a direct producer of competing cell dissociation reagents such as TrypLE, marketed broadly to stem cell researchers with comparable or greater commercial reach.
• Bio-Techne: Bio-Techne (including R&D Systems and Tocris) markets cell culture reagents, dissociation enzymes, and stem cell research tools that overlap directly with ICT's Accutase and Accumax lines.
• Miltenyi Biotec: Miltenyi Biotec sells cell dissociation and cell therapy manufacturing reagents and instruments that directly compete with ICT's AccutaseGMP in the cell therapy bioprocessing market.

Broad incumbents

• Thermo Fisher Scientific: Thermo Fisher is the largest ICT distributor (rebadging Accutase as StemPro) and also develops and sells competing cell culture reagents via its Life Sciences Solutions portfolio, making it both partner and competitor.
• Merck KGaA (Millipore Sigma): Millipore Sigma distributes Accutase through its life science channel while also selling its own competing dissociation reagents (e.g., TrypLE Express via the Sigma legacy line) and broader cell therapy tools.
• Corning Life Sciences: Corning is both an ICT distributor and a major manufacturer of cell culture vessels, media, and ancillary reagents that surround — and partially overlap — ICT's cell detachment product line.
• BD Biosciences: BD distributes Accutase as part of its cell preparation portfolio while also offering its own flow cytometry and cell dissociation reagents, making it a hybrid distribution partner and adjacent competitor.

Regional players

• Pan-Biotech: Pan-Biotech is ICT's licensed co-manufacturer in Germany and an independent producer of competing cell culture media and reagents across European markets.

Others

• Lonza: Lonza is a major cell therapy contract manufacturer and a downstream customer of ancillary reagents like AccutaseGMP; it competes upstream in some bioprocessing consumables rather than in cell detachment itself.
• Sartorius: Sartorius supplies upstream bioprocessing equipment and some cell therapy consumables that bracket ICT's reagent footprint; it is an ecosystem player rather than a direct dissociation-reagent competitor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/accutase
• LinkedInlinkedin.com/company/innovative-cell-technologies-inc

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innovative Cell Technologies